A Systematic Approach For Kinematic Design Of Upper Limb Rehabilitation Exoskeletons

Kinematic structure of an exoskeleton is the most fundamental block of its design and is determinant of many functional capabilities of it. Although numerous upper limb rehabilitation devices have been designed in the recent years, there is not a framework that can systematically guide the kinematic design procedure. Additionally, diversity of currently available devices and the many minute details incorporated to address certain design requirements hinders pinpointing the core kinematics of the available devices to compare them against each other. This makes the review of literature for identifying drawbacks of the state of the art systems a challenging and puzzling task. In fact, lack of a unifying framework makes designing rehabilitation devices an intuitive process and prone to biases from currently available designs. This research work proposes a systematic approach for kinematic design of upper limb rehabilitation exoskeletons based on conceptual design techniques. Having defined a solution neutral problem statement based on the characteristics of an ideal device, the main functionality of the system is divided into smaller functional units via the Functional Decomposition Method. Various directions for concept generation are explored and finally, it has been shown that a vast majority of the current exoskeleton designs fit within the proposed design framework and the defined functionalities

MOESM2 of Individualised treatment targets in patients with type-2 diabetes and hypertension

Additional file 2. Full univariate and multivariate regression data set. Contains patient numbers, univariate odds ratios and multivariate odds ratios for predictors of target achievement at 12 months

Additional file 1: Table S1. of Retinal capillary rarefaction in patients with untreated mild-moderate hypertension

Patient characteristics of hypertensive study population compared to total hypertensive population. Table including patients characteristics of hypertensive study population compared to total hypertensive population. Hypertensive patients showed no difference in age, BMI, gender, duration of disease, blood pressure, heart rate, serum creatinine and serum cholesterol to those of the group with valid evaluation. (DOCX 28 kb

CapillaryRarefactionFinal

original source of the information: collected in the field software used to create the data file: spss statistics 21 description of any abbreviations: see labeling of variables, HDL - high density lipids, LDL - low density lipid

PlosOne_beb

PlosOne_be

Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy-0

<p><b>Copyright information:</b></p><p>Taken from "Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy"</p><p></p><p>Vascular Health and Risk Management 2007;3(4):371-380.</p><p>Published online Jan 2007</p><p>PMCID:PMC2291338.</p><p>© 2007 Dove Medical Press Limited. All rights reserved</p

Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy-1

<p><b>Copyright information:</b></p><p>Taken from "Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy"</p><p></p><p>Vascular Health and Risk Management 2007;3(4):371-380.</p><p>Published online Jan 2007</p><p>PMCID:PMC2291338.</p><p>© 2007 Dove Medical Press Limited. All rights reserved</p

Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy-3

<p><b>Copyright information:</b></p><p>Taken from "Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy"</p><p></p><p>Vascular Health and Risk Management 2007;3(4):371-380.</p><p>Published online Jan 2007</p><p>PMCID:PMC2291338.</p><p>© 2007 Dove Medical Press Limited. All rights reserved</p

Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy-4

<p><b>Copyright information:</b></p><p>Taken from "Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy"</p><p></p><p>Vascular Health and Risk Management 2007;3(4):371-380.</p><p>Published online Jan 2007</p><p>PMCID:PMC2291338.</p><p>© 2007 Dove Medical Press Limited. All rights reserved</p

Additional file 1: Table S1. of The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry

Patient characteristics for the overall group with those receiving an ACE inhibitor other than ramipril being excluded (n = 151) and split by RCT eligibility at baseline and availability of the 12-month follow-up. (DOC 53 kb